Literature DB >> 1240759

Studies on the stability and cellular distribution of dioxopiperazines in cultured BHK-21S cells.

K M Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1240759     DOI： 10.1016/0006-2952(75)90262-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  16 in total

1.  [Effect of the bis-dioxopiperazines ICRF 159 and ICRF 154 on the urinary excretion of cadmium in cadmium-poisoned rats (author's transl)].

Authors:  U Witting; H P Bertram; E Schumacher; G Ritter
Journal:  Int Arch Occup Environ Health       Date:  1979-01-15       Impact factor: 3.015

2.  The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat.

Authors:  T K Yeung; R S Jaenke; D Wilding; A M Creighton; J W Hopewell
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes.

Authors:  J L Buss; B B Hasinoff
Journal:  Agents Actions       Date:  1993-09

4.  The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.

Authors:  R H Wheeler; D J Clauw; R B Natale; R W Ruddon
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  Scavenging effects of dexrazoxane on free radicals.

Authors:  Zhang Junjing; Zhao Yan; Zhao Baolu
Journal:  J Clin Biochem Nutr       Date:  2010-10-29       Impact factor: 3.114

6.  Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).

Authors:  E H Herman; V J Ferrans; H B Bhat; D T Witiak
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Is ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] unusually reactive for an imide?

Authors:  J M Sisco; V J Stella
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Trypanocidal activity of antitumor antibiotics and other metabolic inhibitors.

Authors:  J Williamson; T J Scott-Finnigan
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

9.  The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.

Authors:  B B Hasinoff; S V Kala
Journal:  Agents Actions       Date:  1993-05

10.  Metal binding by pharmaceuticals. Part 5. Interaction of Cd(II), Ni(II) and Pb(II) with the intracellular hydrolysis products of the anti-tumour agent ICRF 159 and its inactive homologue ICRF 192.

Authors:  P M May; M J Willes; D R Williams; A M Creighton
Journal:  Agents Actions       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.